tiprankstipranks
Advertisement
Advertisement

HIND Stock Latest News

Vyome initiated with a Buy at Litchfield Hills
The FlyVyome initiated with a Buy at Litchfield Hills
2d ago
HIND
Vyome Holdings Shareholders Tighten Capital Structure at Meeting
PremiumCompany Announcements
Vyome Holdings Shareholders Tighten Capital Structure at Meeting
6d ago
8K
HIND
Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market
PremiumRatings
Vyome Therapeutics: Undervalued Buy on De-Risked VT-1953 Program and Pivotal Phase 3 Catalyst in a >$2B Orphan Market
12d ago
HIND
Vyome Holdings presents Phase 2 study results on VT-1953
PremiumThe Fly
Vyome Holdings presents Phase 2 study results on VT-1953
14d ago
HIND
Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
PremiumThe Fly
Vyome Holdings to present Phase 2 data on VT-1953 at AACR 2026
30d ago
HIND
Vyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
PremiumThe FlyVyome Holdings reports FY25 revenue $319.7k vs $246.9k last year
1M ago
HIND
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
Premium
Company Announcements
Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics
2M ago
8K
HIND
Vyome Holdings publishes preclinical VT-1908 data
Premium
The Fly
Vyome Holdings publishes preclinical VT-1908 data
3M ago
HIND
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
PremiumCompany Announcements
Vyome Reports Positive Phase 2 Data for VT-1953 Gel
3M ago
8K
HIND
Vyome Holdings funds budget for VT-1953 study
PremiumThe Fly
Vyome Holdings funds budget for VT-1953 study
3M ago
HIND
Vyome Holdings Highlights VT-1953 Market Potential Analysis
PremiumCompany Announcements
Vyome Holdings Highlights VT-1953 Market Potential Analysis
3M ago
8K
HIND
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
PremiumCompany Announcements
Vyome’s LiveChain Signs LOI for Humanyze Note Acquisition
4M ago
8K
HIND
Vyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
PremiumRatingsVyome Holdings: Promising Advancements in MFW Treatment and Strategic Market Positioning Drive Buy Rating
5M ago
HIND
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
Premium
The Fly
Vyome Holdings announces VT-1953 trial achieves primary, secondary endpoints
5M ago
HIND
Vyome Holdings Inc. Reports Post-Merger Financials
Premium
Company Announcements
Vyome Holdings Inc. Reports Post-Merger Financials
6M ago
HIND
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
PremiumRatings
Vyome Holdings: Buy Rating Backed by Promising Pipeline and Strategic Growth Potential
6M ago
HIND
Vyome Holdings files to sell 610K shares of common stock for holders
PremiumThe Fly
Vyome Holdings files to sell 610K shares of common stock for holders
6M ago
HIND
Vyome Holdings Elects Directors at Annual Meeting
PremiumCompany Announcements
Vyome Holdings Elects Directors at Annual Meeting
6M ago
8K
HIND
Vyome Holdings Acquires AI Startup Oculo, Inc.
PremiumCompany Announcements
Vyome Holdings Acquires AI Startup Oculo, Inc.
7M ago
8K
HIND
Vyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
PremiumThe FlyVyome Holdings upgraded to Buy at Maxim on immuno-inflammatory pipeline
7M ago
HIND
Vyome Holdings upgraded to Buy from Hold at Maxim
Premium
The Fly
Vyome Holdings upgraded to Buy from Hold at Maxim
7M ago
HIND
Vyome Holdings acquires MIT AI spinout Oculo Health
Premium
The Fly
Vyome Holdings acquires MIT AI spinout Oculo Health
7M ago
HIND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >